Michael Hund, MBA, is the CEO of EB Research Partnership, a game-changing medical research organization dedicated to curing the life-threatening rare genetic skin disease Epidermolysis Bullosa (EB) by 2030 and pioneering an innovative investment, venture capital, and technology business model. Michael previously served as the Director of Development for the Multiple Myeloma Research Foundation, leading their successful $100 million Curing Cancer Now campaign. Previously, Michael spent over a decade in leadership at the actor and philanthropist Paul Newman’s Hole in the Wall Gang Fund, working on behalf of children and their families battling cancer and other life-threatening illnesses. Michael has spent his career dedicated to transforming healthcare and also founded and runs a real estate investment company. He received his BA in Philosophy from the University of Kansas, CORe credential from Harvard Business School, and MBA from the Yale University School of Management.